Back to Rankings

RWAY

Runway Growth FinanceD
Nasdaq / Financial Services
Last Price
At close
2026-06-03
View Chart
Documents
63
Stored
Transcripts
1
Recent loaded
Latest report
2026-05-09
Investor release

Document history

Earnings documents stored for RWAY.

12 shown
Investor releaseQuarter not tagged2026-05-09

Runway Growth Finance Q1 Earnings Call Highlights

MarketBeat

Interested in Runway Growth Finance Corp.? Here are five stocks we like better. Q1 earnings weakened as total investment income slipped to $29.5 million and net investment income fell to $10.6 million, pressured by repayments, slower originations, and two loans moved to non-accrual status. NAV declined materially, with net asset value per share dropping 9.6% to $12.13 and the portfolio’s fair value falling to $886.3 million; management said fair-value markdowns were driven mainly by multiple compression and watchlist names like Blueshift and Marley Spoon. The SWK transaction is expected to reshape growth, boosting pro forma portfolio size to $1.1 billion and increasing healthcare/life sciences exposure, with the acquired portfolio expected to add to EPS in Q2 and become fully accretive in Q3. Runway Growth Finance (NASDAQ:RWAY) reported lower first-quarter investment income and net investment income as portfolio repayments, slower originations ahead of the SWK transaction closing and new non-accrual loans weighed on results. The business development company generated total investment income of $29.5 million for the quarter ended March 31, 2026, down from $30 million in the fourth quarter of 2025. Net investment income fell to $10.6 million from $11.6 million in the prior quarter, according to Chief Financial Officer and Chief Operating Officer Tom Raterman. → Insider Sales: Top AST SpaceMobile Insider Cuts Postion Over 30% Runway delivered net investment income of $0.29 per share and paid a base dividend of $0.33 per share. Raterman said the company had spillover income of approximately $0.65 per share at quarter-end. The board declared a regular second-quarter distribution of $0.33 per share. “With respect to the dividend, we believe that it's currently set at an appropriate level,” Raterman said. “We are committed to delivering for our shareholders, and our board continues to evaluate future distributions with the goal of maintaining consistency while maximizing returns.” → Light Speed Returns: Corning Cashes In on NVIDIA Growth Runway’s total investment portfolio had a fair value of $886.3 million at the end of the quarter, down 4.4% from $927.4 million at the end of the fourth quarter. Net assets declined to $438.2 million from $485 million, while net asset value per share fell 9.6% to $12.13 from $13.42. Raterman said a subsequent NAV per share figure o...

Investor releaseQuarter not tagged2026-05-08

Runway Growth Finance Corp. Reports First Quarter 2026 Financial Results

GlobeNewswire

Delivered Total and Net Investment Income of $29.5 million and $10.6 million, Respectively Investment Portfolio of $886.3 million Conference Call Today, Thursday, May 7, 2026 at 5:00 p.m. ET MENLO PARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Total investment portfolio of $886.3 million at fair value Total investment income of $29.5 million Net investment income of $10.6 million, or $0.29 per share Net asset value of $438.2 million, or $12.13 per share Dollar-weighted annualized yield on debt investments of 14.2% Four investments completed in new and existing portfolio companies, representing $17.6 million in funded investments Aggregate proceeds of $15.0 million in principal prepayments, $1.9 million from scheduled amortizations, and $2.5 million in sale proceeds from equity Second Quarter 2026 Distributions Declared second quarter 2026 dividend of $0.33 per share “In the first quarter, Runway Growth focused on the close and integration of the SWK Holdings acquisition, while navigating a volatile macroeconomic backdrop,” said David Spreng, Founder and CEO of Runway Growth. “With the transaction now complete, we are well positioned to selectively capitalize on opportunities and expand our exposure to leading healthcare and life sciences companies. Today, we also announced a new $15 million share repurchase authorization, which we expect to utilize as we believe our shares present an extremely compelling value relative to the outlook of the business.” First Quarter 2026 Operating Results Total investment income for the quarter ended March 31, 2026 was $29.5 million, compared to $35.4 million for the quarter ended March 31, 2025. The Company's dollar-weighted annualized yield on average debt investments for the quarter ended March 31, 2026 was 14.2%. The Company calculates the yield on dollar-weighted debt investments for any period measured as (1) total investment-related income during the period divided by (2) the daily average of the fair value of debt investments, including investments on non-accrual status, outstanding during the period. Tota...

Investor releaseQuarter not tagged2026-05-08

Runway Growth Finance Corp. (RWAY) Q1 Earnings and Revenues Lag Estimates

Zacks

Runway Growth Finance Corp. (RWAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -7.44%. A quarter ago, it was expected that this company would post earnings of $0.36 per share when it actually produced earnings of $0.32, delivering a surprise of -11.11%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Runway Growth Finance Corp., which belongs to the Zacks Financial - SBIC & Commercial Industry industry, posted revenues of $29.45 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 1.14%. This compares to year-ago revenues of $35.4 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Runway Growth Finance Corp. shares have lost about 23.7% since the beginning of the year versus the S&P 500's gain of 7.6%. While Runway Growth Finance Corp. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Runway Growth Finance Corp. was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market...

Investor releaseQuarter not tagged2026-05-08

Runway Growth Finance Corp. (RWAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

For the quarter ended March 2026, Runway Growth Finance Corp. (RWAY) reported revenue of $29.45 million, down 16.8% over the same period last year. EPS came in at $0.29, compared to $0.42 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $29.79 million, representing a surprise of -1.14%. The company delivered an EPS surprise of -7.44%, with the consensus EPS estimate being $0.31. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Runway Growth Finance Corp. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Investment income- From non-control/non-affiliate- Interest income: $23.59 million versus the two-analyst average estimate of $25.28 million. Investment income- From non-control/non-affiliate- Dividend income: $0.25 million versus $0.25 million estimated by two analysts on average. Investment income- From non-control/non-affiliate- Payment in-kind interest income: $4.63 million versus $4.26 million estimated by two analysts on average. View all Key Company Metrics for Runway Growth Finance Corp. here>>> Shares of Runway Growth Finance Corp. have returned +3.2% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Runway Growth Finance Corp. (RWAY) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Investor releaseQuarter not tagged2026-05-08

Runway Growth (RWAY) Q1 2026 Earnings Transcript

Motley Fool

Image source: The Motley Fool. Thursday, May 7, 2026 at 5:00 p.m. ET Chief Executive Officer and Chief Investment Officer — David Spreng Chief Financial Officer and Chief Operating Officer — Thomas B. Raterman Senior Vice President, Finance and Accounting — Carmela Thompson David Spreng, chief executive officer and chief investment officer of Runway Growth Capital LLC, our investment adviser, Thomas B. Raterman, chief financial officer and chief operating officer, and Carmela Thompson, our senior vice president, finance and accounting. Runway Growth Finance Corp.'s first quarter 2026 financial results were released just after today's market close and can be accessed from Runway Growth Finance Corp.'s investor relations website at investors.runwaygrowth.com. We have arranged for a replay of the call to be available on the Runway Growth Finance Corp. web page. During this call, I want to remind you that we may make forward-looking statements based on current expectations. The statements on this call that are not purely historical are forward-looking statements. These forward-looking statements are not a guarantee of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements, including, without limitation, market conditions caused by uncertainties surrounding interest rates, changing economic conditions, and other factors we identify in our filings with the SEC. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions can prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions can be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained on this call are made as of the date hereof, and Runway Growth Finance Corp. assumes no obligation to update the forward-looking statements or events. To obtain copies of SEC-related filings, please visit our website. With that, I will turn the call over to David. David Spreng: Thank you, Quinlan, and thank you, everyone, for joining us this evening to discuss our first quarter 2026 results. Today, I will highlight notable developments from the quarter, provide an update on recent leadership appointments, and offer additiona...

Investor releaseQuarter not tagged2026-05-08

Runway Growth Finance Corp. Q1 2026 Earnings Call Summary

Moby

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. The closing of the SWK transaction marks a milestone in diversifying the portfolio, specifically increasing Healthcare and Life Sciences exposure to 32% of fair value. Management intentionally slowed new investment evaluations during the quarter to focus on integrating the SWK portfolio and post-transaction balance sheet. A series of leadership changes were announced, including Tom Raterman transitioning to Vice Chairman and Carmela Thomson becoming CFO, to align with the firm's next phase of growth. The software investment thesis remains constructive, focusing on late-stage businesses with mission-critical functions and high switching costs that can leverage AI for operational optimization. Performance attribution for the quarter was impacted by elevated prepayments in late 2025 and slower originations ahead of the SWK deal close. Management asserts that broader credit metrics show stability despite macro headwinds, with default rates remaining at manageable levels across the industry. The SWK portfolio is expected to contribute approximately $0.03 per share to NII in Q2, though this will be more than offset by a $0.06 per share headwind from new nonaccruals. Management expects the SWK acquisition to be fully accretive to earnings per share by the third quarter of 2026. A new $15 million share repurchase program has been authorized through May 2027, to be partially funded by upcoming loan repayments. The firm plans to be highly selective in capitalizing on a robust pipeline across technology, healthcare, and consumer sectors following the integration of SWK. Future capital allocation will balance share repurchases at current NAV discounts against new investments that offer the best risk-return trade-offs. Two loans, Marley Spoon and BlueShift, were moved to Category 5 and nonaccrual status, which was the primary driver for the weighted average risk rating increase to 2.67. NAV per share decreased to $12.13 at quarter end, impacted by market multiple declines and specific marks on watchlist names; subsequent to quarter end, the NAV further decreased to $11.93 due to approximately $7.7 million in estimated SWK transaction costs. The company recorded approximately $0.02 to $0.03 per share in one-time deferred...

TranscriptFY2026 Q12026-05-07

FY2026 Q1 earnings call transcript

Earnings source - 46 paragraphs
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Runway Growth Finance first quarter 2026 earnings conference call. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Quinlan Abel, Assistant Vice President, Investor Relations. Please go ahead.

Quinlan Abel

Thank you, operator. Good evening, everyone, and welcome to the Runway Growth Finance conference call for the 1st quarter ended March 31st, 2026. Joining us on the call today from Runway Growth Finance are David Spreng, Chief Executive Officer and Chief Investment Officer of Runway Growth Capital LLC, our investment advisor, Tom Raterman, Chief Financial Officer and Chief Operating Officer, and Carmela Thomson, our Senior Vice President, Finance and Accounting. Runway Growth Finance's 1st quarter 2026 financial results were released just after today's market close and can be accessed from Runway Growth Finance's investor relations website at investors.runwaygrowth.com. We have arranged for a replay of the call to be available on the Runway Growth Finance webpage. During this call, I want to remind you that we may make forward-looking statements based on current expectations. The statements on this call that are not purely historical are forward-looking statements.

Quinlan Abel

These forward-looking statements are not a guarantee of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements, including, without limitation, market conditions caused by uncertainties surrounding interest rates, changing economic conditions, and other factors we identify in our filings with the SEC. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions can prove to be inaccurate. As a result, the forward-looking statements based on those assumptions can be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained on this call are made as of the date hereof, and Runway Growth Finance assumes no obligation to update the forward-looking statements or subsequent events. To obtain copies of SEC-related filings, please visit our website.

Quinlan Abel

With that, I will turn the call over to David.

David Spreng

Thank you, Quinlan, and thank you, everyone, for joining us this evening to discuss our first quarter 2026 results. Today, I will highlight notable developments from the quarter, provide an update on recent leadership appointments, and offer additional color on our approach to software investments. Tom will take a deeper dive into our financial performance and portfolio metrics. I want to start by saying I am truly excited about the closing of the SWK transaction last month. It is a milestone moment for our investors and our team. In tandem with the closing of the deal, we are pleased to welcome JD Tamas as a Managing Director of Healthcare and Life Sciences Investing, where he will leverage his extensive expertise to further strengthen our investment platform. This acquisition has already strengthened our position in healthcare and further diversified our portfolio.

David Spreng

JD's appointment is both a logical progression and a great opportunity as we further optimize our portfolio in the coming quarters. I would also like to congratulate Avisha Khubani on her promotion to Chief Credit Officer of our investment advisor, Runway Growth Capital. Since joining Runway in 2018, she has held a range of roles across portfolio monitoring and management, analytics, and valuation, bringing a deep understanding of our portfolio and credit discipline to this position. In addition, we are announcing today that Tom Raterman, our CFO and COO, who joined me shortly after I started the firm, will become Vice Chairman of Runway Growth Capital, effective June 30, 2026. He will be stepping back from his day-to-day roles at the BDC, including as CFO and COO, to focus on strategic initiatives that include portfolio optimization, platform-level M&A, capital market transactions, and capital formation.

David Spreng

Tom will continue to play an integral role for the BDC, serving on our investment committee and assisting with special situation assets. In tandem with this news, we are very pleased to share that Carmela Thomson, our SVP, Finance and Accounting, will become CFO at that time. Carmela joined our firm in June 2021 from KPMG and played an integral role in our IPO later that year. Since then, Carmela has contributed meaningfully to our financial reporting processes and capital raising efforts and has managed important aspects of portfolio accounting and operations. Carmela's experience and expertise give her a strong understanding of Runway's financial strategy, capital structure, and portfolio construction as we enter our next phase. Lastly, I am energized to be returning to the role of Chief Investment Officer of our advisor.

David Spreng

Our efforts since joining the BC Partners Credit platform have put the right pieces on the chessboard, and now we're going to work with this refreshed team to maximize returns for our shareholders. To that end, I'd like to thank Greg Greifeld for his dedication over the years at Runway and wish him well in his future endeavors. We are confident in this experienced leadership team and the contributions JD, Avisha, and Carmela will make, strengthening our origination and investment capabilities and financial operations and supporting our ability to deliver superior risk-adjusted returns. Turning to our portfolio activity for the quarter, it is important to note that as we work to close the SWK transaction, we temporarily slowed our evaluation of new opportunities in the pipeline to focus on integrating the SWK portfolio and post-transaction balance sheet.

David Spreng

With the transaction now behind us, we are positioned to be very selective in capitalizing on a robust pipeline moving forward. We are even more confident in our ability to source high-quality investments across our core sectors, technology, healthcare, and select consumer products and services. In the first quarter, Runway Growth Finance delivered total investment income of $29.5 million and net investment income of $10.6 million. During the quarter, we completed four investments in new and existing portfolio companies, representing $17.6 million in funded investments. We also completed an additional debt commitment of $46.3 million, which will be partially funded during the second quarter of 2026. These investments included the following.

David Spreng

First, the completion of a new $7.5 million investment to HR Pharmaceuticals, a founder-owned medical products platform specializing in the development, manufacturing, and supply of branded consumable products serving the acute and home care markets. We funded $5.5 million at close, along with $2 million of preferred equity financing. Second, we completed an additional debt commitment of $46.3 million to 13 Scents, a digitally native fragrance brand, which we expect will be partially funded during the second quarter of 2026. Finally, we completed three follow-on investments with an aggregate amount of $10.1 million to three existing portfolio companies. Subsequent to the first quarter, we continue to evaluate compelling opportunities that meet our high standards, while strategically increasing our exposure to innovative healthcare and life science companies with durable long-term business models.

David Spreng

We look forward to updating you on these opportunities in further detail as appropriate. Turning to the ongoing market dynamics facing the sector. As discussed during our fourth quarter 2025 earnings call, the recent debate around software and AI disruption has contributed to increased scrutiny of private credit and has been further compounded by headlines around elevated redemptions in evergreen funds. While media coverage has leaned into this narrative, it has failed to recognize the resilience of actual credit performance despite macro and rate headwinds over the last few years. Underlying fundamentals remain solid, with default rates at manageable levels and broader credit metrics showing stability rather than stress. In terms of the venture market specifically, PitchBook/NVCA finds that activity remains modest overall and robust at the top end of the market, with record levels of capital deployed.

David Spreng

The data also points to resilience in early-stage investing and sustained interest in high-growth areas like AI. This suggests that while the market is selective, there are clear pockets of strength and opportunity underpinning venture activity. Overall, we believe we are well-positioned for strong long-term performance despite the current sentiment, supported by our rigorous investment approach and our seasoned leadership team, which brings decades of venture capital experience. Our confidence is supported by our expanded platform, which is supported by the expertise of BC Partners Credit and further enhanced by the acquisition of SWK Holdings. With the closing of the SWK acquisition, we have meaningfully reconstructed our portfolio with attractive diversification in key sectors like healthcare, with stronger future earnings power. Today, we have a more diversified, balanced, and enhanced portfolio, with the healthcare and life sciences sector comprising 32% of the portfolio at fair value.

David Spreng

This transformation is an important context as we discuss the quarter's results. With respect to our software portfolio and approach to software investing, we maintain our constructive long-term thesis on software and technology, our diligent approach to portfolio construction, and emphasis on risk mitigation. Across multiple economic cycles and market dislocations, our focus on high-quality, late-stage companies with proven fundamentals has contributed to the resilience of our portfolio over time. We remain confident in our existing software positions and continue to evaluate compelling opportunities in the sector. Our software investments are high quality, late-stage businesses characterized by mission-critical functions, long diligence and implementation cycles, and strong competitive moats, which include deep domain expertise, high switching costs, and diversified customer bases. We believe these attributes position our portfolio companies to not only coexist with AI, but to leverage it to optimize operations and accelerate market penetration.

David Spreng

We apply the same exceptional level of diligence and rigor in underwriting our software investments that we do to our portfolio at large. We remain confident in our pipeline and optimistic about the year as we realize the benefits of integrating the SWK portfolio and drive stronger outcomes for both our borrowers and our shareholders. Now, Tom, over to you.

Tom Raterman

Thank you, David. In the first quarter, we generated total investment income of $29.5 million and net investment income of $10.6 million, a decrease compared to $30 million and $11.6 million in the fourth quarter of 2025. Our weighted average portfolio risk rating increased to 2.67 in the first quarter of 2026, compared to 2.45 in the fourth quarter of 2025. Our weighted average risk rating changed primarily as a result of moving two loans, Marley Spoon and Blueshift, to category 5 in non-accrual status. Our weighted average risk rating calculated without these two specific loans moved from 2.67 to 2.37. Our rating system is based on a scale of 1 to 5, where 1 represents the most favorable credit rating.

Tom Raterman

Our total investment portfolio had a fair value of $886.3 million, a decrease of 4.4% from $927.4 million in the fourth quarter of 2025. As of March 31st, 2026, Runway Growth Finance had net assets of $438.2 million, decreasing from $485 million in the fourth quarter of 2025. NAV per share was $12.13, a decrease of 9.6% compared to $13.42 as of December 31st, 2025. The NAV per share disclosed subsequent to quarter end in connection with the SWK closing of $11.93, primarily reflected estimated transaction costs of $7.7 million.

Tom Raterman

In discussing our NAV for the quarter, it's important to contextualize our go-forward portfolio and the financial benefits of the SWK acquisition. On a pro forma basis, our portfolio is $1.1 billion, more than offsetting the impact of repayments in the Runway portfolio during 2025. It also drives diversification in terms of both industry exposure and the reduction of average loan size by 11%. Healthcare and life sciences will now account for 32% of our portfolio and 30% of our debt portfolio, compared to 13% and 12% respectively at the end of first quarter. We expect to see a positive contribution to the portfolio's return profile over the balance of the year. Beyond financial contributions, our strength and origination capabilities enhance our ability to source high-quality investments and selectively upsize existing commitments.

Tom Raterman

Moving back to the quarter, we delivered $0.29 per share of net investment income and a base dividend of $0.33 per share. At quarter end, we had spillover income of approximately $0.65 per share. Net investment income this quarter was impacted by the acceleration of one-time deferred debt costs, as well as a smaller average portfolio size due to elevated prepayments in the second half of 2025, the effects of which were further compounded by slower originations ahead of the deal close, as we described earlier. Looking ahead to next quarter, we expect contributions from the fully integrated SWK portfolio and a lag in associated management fees to benefit NII by approximately $0.03 per share. However, we expect this benefit will be more than offset by the impact of Marley Spoon and Blueshift being placed on non-accrual late in Q1.

Tom Raterman

The full quarter earnings impact of these new non-accruals of $0.06 per share will be reflected in Q2. We are actively working with the management teams at Marley Spoon, Blueshift, and Mingle Health and seek to achieve optimal outcomes for the portfolio. These situations are dynamic and, in the case of Marley Spoon, very complex, and as we've seen in the past, can take time to fully resolve. We do not see any thematic drivers to these recent credit downgrades. There are situations we have been monitoring and decided this was the prudent course of action to take at this time. Although our team puts maximum effort into avoiding these situations, some level of defaults are unavoidable, and we're working diligently to resolve them. With respect to the dividend, we believe that it's currently set at an appropriate level.

Tom Raterman

We are committed to delivering for our shareholders, and our board continues to evaluate future distributions with the goal of maintaining consistency while maximizing returns. Our debt portfolio generated a dollar-weighted average annualized yield of 14.2% for the first quarter of 2026. Consistent with 14.2% in the fourth quarter of 2025, and declining from 15.4% in the same period last year. Moving on to expenses. Total operating expenses were $18.8 million, an increase from $18.4 million in the fourth quarter of 2025. We recorded a net realized gain on investments of $1.3 million during the first quarter of 2026, compared to a realized loss on investments of $380,000 during the fourth quarter of 2025.

Tom Raterman

During the first quarter, we experienced one full repayment and one partial repayment totaling $15 million, scheduled amortization of $1.9 million, and $2.5 million in equity proceeds. We remain focused on maximizing value over both the short and long term and continue to monitor the portfolio closely. Overall, we believe that downside risk is manageable and that our portfolio is well-positioned to deliver stable results. Our confidence in the portfolio is supported by several key metrics which support a more balanced and right-sized mix of investments. Prior to the closing of the SWK transaction, our top 10 investments accounted for 54% of the portfolio and now account for only 43%. When looking at the breakdown of verticals within the portfolio, they are now more balanced across technology, financials, healthcare, and select consumer products and services.

Tom Raterman

Over half of our portfolio companies are cash flow positive, underscoring the strong fundamentals our portfolio is built on. Within our software portfolio specifically, 62% of the companies are cash flow positive, 100% of our loans have financial covenants, and the weighted average fair value as a percent of cost, excluding non-accruals, was 97%. 94% of the loans in our software portfolio are sponsored. Each position in our portfolio undergoes a comprehensive evaluation process internally on a quarterly basis and periodically by a third party. For perspective, every material software investment in our portfolio was reviewed by a third-party valuation specialist in Q1. The portfolio was constructed intentionally with 98% first lien exposure and well-diversified exposure across end markets. These results underscore the strength of our software portfolio and the diligence we apply to loans in the space.

Tom Raterman

Please refer to our earnings presentation for additional detail on our software exposure. As of March 31st, 2026, our leverage ratio and asset coverage ratio were 0.98 and 2.02 respectively, compared to 0.90 and 2.11 respectively, at the end of the fourth quarter of 2025. Our total available liquidity was $372.3 million, including unrestricted cash and equivalents. We have borrowing capacity of $370 million under our KeyBank credit facility. On a pro forma basis, immediately following the SWK transaction close, our leverage ratio, asset coverage ratio, and total available liquidity were approximately 1.2, 1.84, and $231.8 million, respectively.

Tom Raterman

As of March 31st, 2026, we had a total of $179.2 million in unfunded commitments, which was comprised of $156.3 million to provide debt financing to our portfolio companies and $22.8 million to provide equity financing through our JV with Cadma. Approximately $23.3 million of our unfunded debt commitments are eligible to be drawn based on achieved milestones. On May 5th, 2026, our board declared a regular distribution for the second quarter of 2026 of $0.33 per share. While there may be some variability in earnings on a quarter-to-quarter basis, we're confident in the long-term trajectory of our return profile and the strength of our combined portfolio. Finally, today, we are announcing a new share repurchase program for $15 million, which will expire on May 7th, 2027.

Tom Raterman

Thoughtful capital allocation remains a priority, and at current levels, we believe Runway's common shares present a highly attractive opportunity. We expect repurchases to be partly funded by proceeds from loan repayments in the coming quarters. With that, operator, we can open the line for Q&A.

Operator

Thank you. As a reminder, to ask a question, you will need to press star one one on your telephone. To remove yourself from the queue, you may press star one one again. Again, that's star one one on your telephone to ask a question. Please stand by while we compile the Q&A roster. Our first question comes from the line of Erik Zwick of Lucid Capital Markets. Your question please, Erik.

Erik Zwick

Thanks. Good afternoon, everyone. First, David, you mentioned a lot of kind of personnel changes and promotions, and I know Tom's on the line. Tom, congratulations on your next position and congrats to any of those else listening online. One, I wanted to start maybe with a question for Tom. Just trying to potentially understand the kind of one-time expenses that may have been recorded in the quarter related to both the SWK acquisition and also, I think, you mentioned some accelerated debt expense as well. Just trying to kind of drill down to maybe what a more kind of core run rate might have been.

Tom Raterman

Yeah. There was about $0.02 or $0.03 related to the early redemption of our baby bonds. If you recall, at the end of January, beginning of February, we did a new baby bond offering and we redeemed our 8% notes.

Tom Raterman

That's the number there. There were no SWK expenses directly. Most all of those would be capitalized into the transaction. You know, there's a, you know, could be some modest amount just in terms of allocation of personnel that caused our allocations to the BDC change a little bit. It would be a rounding error.

Erik Zwick

Got it. That's helpful. Thanks.

Tom Raterman

Thanks for the congrats.

Erik Zwick

Yeah, absolutely. You're welcome. Other one I wanted to ask, just along the lines of the new share repurchase authorization. You know, given Blueshift and Marley Spoon moving to a non-accrual and creating a little bit of, you know, earnings headwind, just how do you weigh, you know, in your mind, how do you evaluate the use of capital in terms of investing into new portfolio companies that would generate income versus buying back shares?

Tom Raterman

Yeah, it's always a tough balancing act between those two because purchasing shares at this level, at this percent of NAV is immediately accretive. What really guides that is our excess borrowing base, if you will, and our leverage ratio that we calculate. We wanna keep those two in check. We wanna make sure we maintain adequate dry powder. We'll just be biased towards, for the deals that come in, for those that have the best risk-return trade-off, choose the higher yielding ones, probably the smaller-sized transactions, all within our stated risk parameters.

Erik Zwick

Great. Thanks for taking my questions.

Tom Raterman

Sure.

Operator

Thank you. Once again, to ask a question, you will need to press star one one on your telephone. To remove yourself from the queue, you may press star one one again. Our next question comes from the line of Christopher Nolan of Ladenburg Thalmann. Your line is open, Christopher.

Christopher Nolan

Hi, and echo congratulations, Tom, on your next move, and congratulations everyone who got the step. What was the driver for the unrealized appreciation charges again? I think you misaddressed it in the comments, but I missed it.

Tom Raterman

The changes in fair value, the impact on NAV were really related primarily to, put it into two buckets. About a third, or just under a third, was related to declines in the, in the market multiples. The majority of it was related to the watchlist names, primarily Blue Shift and Marley Spoon.

Christopher Nolan

Great. I think you mentioned that the drag on earnings from those two would be roughly $0.06 a quarter?

Tom Raterman

That's correct. You know, you know, our watchlist, you know, is about six names. A number of them are marked, you know, at that 50% range. We think those are very fair marks. Those workouts will take varying times to sort through. They've got different levels of complexity. So, it will take a little bit of time to replace those with earning assets. There's a game plan for each of them that's being, you know, fully adjudicated.

Christopher Nolan

Okay. Turning to SWK, I know you mentioned earlier that in earlier calls that it would be accretive to earnings. Do you have any sort of timeframe when you expect it to be accretive to EPS?

Tom Raterman

It should be beginning to be accretive to EPS in Q2 and then fully accretive in Q3. The reason I say partially accretive is because it closed on April 6th as opposed to March 31st.

Christopher Nolan

Great. Thank you.

Operator

Thank you. I would now like to turn the call back over to David Spreng for closing remarks. Sir?

David Spreng

Thank you, operator, and thank you all for joining us today. We look forward to updating you on our second quarter financial results in August.

Operator

This concludes today's conference call. Thank you for participating. You may now disconnect.

Investor releaseQuarter not tagged2026-05-06

Runway Growth Finance Corp. Announces Second Quarter 2026 Dividend of $0.33 per Share

GlobeNewswire

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a second quarter 2026 cash distribution of $0.33 per share. The following shows the key dates of the second quarter 2026 dividend: Declaration Date: May 5, 2026 Record Date: May 18, 2026 Payment Date: June 2, 2026 Runway Growth generally intends to distribute, out of assets legally available for distribution, substantially all of its available earnings, on a quarterly basis, subject to the discretion of the Board of Directors. Any distribution by the Company will depend on the Company's earnings, financial condition, maintenance of regulated investment company status for income tax purposes, compliance with applicable business development company regulations and such other factors as the Board of Directors may deem relevant from time to time. The Company also maintains an “opt out” dividend reinvestment plan, as amended, for its stockholders. As a result, if the Company declares a distribution, then stockholders who have not opted out of the dividend reinvestment plan will have their cash dividends automatically reinvested in additional shares of the Company’s common stock. About Runway Growth Finance Corp. Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Runway Growth is a closed-end investment fund that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. Runway Growth is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P., and led by industry veteran David Spreng. For more information, please visit www.runwaygrowth.com. Forward-Looking Statements Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and...

Investor releaseQuarter not tagged2026-04-15

Runway Growth Finance Corp. Announces Date for First Quarter 2026 Financial Results and Conference Call

GlobeNewswire

MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY), (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET). To participate in the conference call or webcast, participants should register online at the Runway Growth Investor Relations website. Participants are requested to register a day in advance or at a minimum 15 minutes before the start of the call. The earnings call can also be accessed through the following links: Conference Call Webcast A replay of the webcast will be available two hours after the call and archived on the same web page for 90 days. About Runway Growth Finance Corp. Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Runway Growth is a closed-end investment fund that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. Runway Growth is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P., and led by industry veteran David Spreng. For more information, please visit www.runwaygrowth.com. Forward-Looking Statements Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in forward-looking statements as a result of a number of factors, including those described from time to time in Runway Growth’s filings with the Securities and Exchange Commission. Runway Growth undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release. IR Contacts Taylor Donahue, Prosek Partners, r...

Investor releaseQuarter not tagged2026-04-07

Runway Growth Finance Corp. Closes Acquisition of SWK Holdings Corporation and Provides First Quarter 2026 Business and Portfolio Update

GlobeNewswire

Closed Acquisition of SWK Holdings Corporation, Expanding Healthcare and Life Sciences Exposure and Scaling Platform Completed Four Investments in New and Existing Portfolio Companies Representing $17.6 Million in Funded Investments MENLO PARK, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY), (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it has completed its previously announced acquisition of SWK Holdings Corporation (“SWK” or “SWK Holdings”). Additionally, the Company today provided an operational and portfolio update for the quarter ended March 31, 2026, as well as an update on investment team changes. Runway Growth’s Founder and CEO David Spreng said, “We are pleased to announce the successful closing of our acquisition of SWK, which represents a meaningful step forward in advancing our ongoing portfolio optimization and diversification strategy. This transaction enhances our scale, deepens our investment capabilities in healthcare and life sciences, and further diversifies our portfolio. Notably, our investment adviser committed an additional $9.0 million in cash as consideration to the stockholders of SWK, highlighting the team’s confidence in the strength of our platform against the current macro backdrop, as well as its alignment with the BDC and its shareholders. Looking ahead, we believe we are well positioned to build on our diversified portfolio and capitalize on an improving opportunity set across verticals.” Acquisition of SWK Holdings Corporation Runway Growth’s acquisition of SWK, a life science focused specialty finance company that provides minimally dilutive financing to small- and mid-sized commercial-stage healthcare companies, closed on April 6, 2026. The final purchase price for the transaction was $249.0 million, including $75.5 million in Runway Growth shares valued at closing NAV per share of $11.93 and $173.5 million in cash. The acquisition is expected to be accretive to net investment income and enhance the Company’s earnings power, supporting improved dividend coverage and long-term return potential. As previously disclosed, the total merger consideration was determined based on SWK’s final NAV, which was struck 48 hours prior to closing (excluding Sundays...

Investor releaseQuarter not tagged2026-03-13

Runway Growth (RWAY) Earnings Call Transcript

Motley Fool

Image source: The Motley Fool. Thursday, March 12, 2026 at 5 p.m. ET Chief Executive Officer — David R. Spreng Chief Investment Officer, Runway Growth Capital LLC — Greg Greifeld Chief Financial Officer and Chief Operating Officer — Thomas B. Raterman Need a quote from a Motley Fool analyst? Email [email protected] David R. Spreng, Chief Executive Officer; Greg Greifeld, Chief Investment Officer of Runway Growth Capital LLC, our investment adviser; and Thomas B. Raterman, Chief Financial Officer and Chief Operating Officer. Runway Growth Finance Corp.'s fourth quarter and fiscal year ended 2025 financial results were released just after today's market close and can be accessed from Runway Growth Finance Corp.'s investor relations website at investors.runwaygrowth.com. We have arranged for a replay of the call to be available on the Runway Growth Finance Corp. web page. During this call, I want to remind you that we may make forward-looking statements based on current expectations. The statements on this call that are not purely historical are forward-looking statements. These forward-looking statements are not a guarantee of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements, including, without limitation, market conditions caused by uncertainties surrounding interest rates, changing economic conditions, and other factors we identify in our filings with the SEC. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions can prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions can be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained on this call are made as of the date hereof, and Runway Growth Finance Corp. assumes no obligation to update the forward-looking statements or subsequent events. To obtain copies of SEC-related filings, please visit our website. With that, I will turn the call over to David. Thank you, Quinlan, and thanks, everyone, for joining us. David R. Spreng: Good evening to discuss our fourth quarter and full year 2025 financial results. Today, I will discuss our highlights for the quarter and the year and provide an update on ou...

Investor releaseQuarter not tagged2026-03-13

Runway Growth Finance Corp. Q4 2025 Earnings Call Summary

Moby

Management attributed 2025 performance to a disciplined investment approach during a year of high volatility driven by tariff uncertainty, interest rate shifts, and AI disruption. The company is actively transitioning toward a lower-risk profile by reducing average position sizes and increasing sector diversification to enhance risk-adjusted returns. The pending acquisition of SWK Holdings is a central strategic pivot to strengthen capabilities in health care and life sciences, providing optionality beyond the core technology focus. Management maintains high conviction in its software portfolio, emphasizing that their underwriting focuses on mission-critical functions with high switching costs and AI-resilient business models. Operational integration with the BC Partners credit ecosystem has expanded the deal funnel, allowing for larger-scale opportunities and shared resources in portfolio monitoring. The company is prioritizing first-lien senior secured positions to late-stage companies to ensure durable growth and capital preservation across economic cycles. The SWK Holdings transaction is now expected to close in early April 2026, which management anticipates will stabilize the asset base against elevated prepayments. Q1 2026 earnings are expected to face a $0.02 per share headwind due to one-time charges from the full redemption of 8% notes and partial redemption of 7.5% notes. Management projects the SWK deal will be accretive to net investment income in the mid-single digits and support modest ROE expansion upon closing. The company plans to target a fully levered run rate between 1.2x and 1.3x post-acquisition, with flexibility to temporarily exceed this to protect earnings power during portfolio resets. The first distribution from the CADMA joint venture is expected in Q2 2026, signaling a renewed effort to scale that partnership's earnings contribution. A one-time charge is anticipated in Q1 2026 related to the strategic refinancing of unsecured notes to extend the debt maturity ladder and reduce the cost of funds. The loan to Domingo Healthcare remains the sole non-accrual item, representing only 0.25% of the total investment portfolio at fair value. Stock repurchases were legally restricted during Q4 due to the pending SWK acquisition and associated blackout periods, with a potential restart in May 2026. The weighted average portfolio risk rating...

As of 2026-05-18 • Updated weeklySource: Earnings sourceIngestion runbook